The Effect of Systemic Administration of Zinc on The Gingival Crevicular Fluid Level of Total Oxidant Capacity in Type 2 Diabetic Patients with Stage II and III Periodontitis After Non-Surgical Periodontal Therapy: A Randomized Clinical Trial | ||
| Advanced Dental Journal | ||
| Volume 5, Issue 4, October 2023, Pages 883-900 PDF (622.62 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/adjc.2023.216709.1337 | ||
| Authors | ||
| Abdulrahman Abdulqawi Abdulrab1; Enji Ahmed1, 2; Mona Darhous1; Olfat Shaker3; Weam Ahmed Elbattawy* 1 | ||
| 1Oral Medicine and Periodontology Department, Faculty of Dentistry, Cairo University, Cairo, Egypt | ||
| 2Oral Medicine and Periodontology Department, Faculty of Dentistry, The British University in Egypt, El Sherouk city, Cairo, Egypt. | ||
| 3Department of Biochemistry, Faculty of Medicine, Cairo University | ||
| Abstract | ||
| Objectives: This study aimed to evaluate the effect of systemic administration of zinc supplementation on the total oxidant capacity in the gingival crevicular fluid level of controlled type 2 diabetic patients with stage-II and III periodontitis after non-surgical periodontal therapy. Materials and Methods: This clinical trial was registered at ClinicalTrials.gov Identifier: ID: NCT03923829 on April 23, 2019. Twenty-eight controlled type 2 diabetic patients with periodontitis stages II or III were randomly assigned into two groups, test and control where both received non-surgical periodontal therapy while the test group received 50 mg zinc one tablet/day for 12 weeks. Total oxidant capacity (TOC) level was measured in GCF of both groups at baseline and after 3 months. HbA1c level, GI, PPD and CAL were also reported at baseline and 3 months postoperatively. Results: After 3 months a statistically significant decrease in mean TOC µmol/L was reported in both groups being more significantly lower in test group. No significant difference in mean percentage HbA1c was reported after 3 months neither within each group nor between the two groups. In both groups there was a significant reduction in GI scores, PPD reduction and CAL gain after 3 months with no significant difference between them, while the test group showed significantly lower GI than the control group. Conclusions: Systemic administration of zinc supplements as an adjunct to non-surgical periodontal therapy might improve the clinical parameters and oxidative stress in T2DM patients with stage II-III periodontitis. | ||
| Keywords | ||
| Periodontitis; Zinc; Type 2 Diabetes Mellitus; total oxidant capacity; GCF | ||
|
Statistics Article View: 185 PDF Download: 244 |
||
